Drug delivery

ClearPoint Neuro and Higgs Boson Health Announce Collaboration

Retrieved on: 
星期二, 五月 3, 2022
Interface (computing), COVID-19, U.S. Securities and Exchange Commission, Organizational founder, Lists of diseases, Insurance, Nasdaq, GLOBE, CNS, Brain–computer interface, Company, Patient satisfaction, Patient, App, COVID, Paper, Security (finance), Partnership, Clinical trial, FDA, Family, Therapy, Higgs boson, Particular, Duke University, Quality of life, Spine, Efficiency, Education, BCI, Solution, Drug delivery, Research, CEO, Biopsy, Growth, Patient education, Search for the Higgs boson, Medical device, Medicine, Neurosurgery, Brain, Gastroenterology

Higgs Boson is proud to partner with ClearPoint Neuro to advance targeted pharmaceutical delivery and deliver cutting-edge Brain Computer Interface (BCI) solutions.Together, we will help patients and families navigate their condition, clinical studies, procedures and stay on track for the best outcomes, said Rajeev Dharmapurikar, CEO of Higgs Boson Health.

Key Points: 
  • Higgs Boson is proud to partner with ClearPoint Neuro to advance targeted pharmaceutical delivery and deliver cutting-edge Brain Computer Interface (BCI) solutions.Together, we will help patients and families navigate their condition, clinical studies, procedures and stay on track for the best outcomes, said Rajeev Dharmapurikar, CEO of Higgs Boson Health.
  • Studies in spine surgery and breast surgery have confirmed the effectiveness of Higgs Bosons care navigation app in improving important patient-reported health outcomes.
  • Higgs Bosons partnership with ClearPoint Neuro exemplifies our shared patient-centric approach.
  • Based in Durham, NC, Higgs Boson Health partners with leading medical device companies and academic health systems.To learn more, visit www.higgsbosonhealth.com .

Nanomedicine Market to Reach $393.04 Bn, Globally, by 2030 at 9.2% CAGR: Allied Market Research

Retrieved on: 
星期二, 三月 15, 2022
Nanotechnology, Degenerative disease, Nanomedicine, Urology, Treatment, Investment, Diagnosis, Government, CAGR, Lists of countries and territories, Neurology, Awareness, Private sector, Drug delivery, Regenerative medicine, Prevalence, Cancer, Incidence, Growth, Vaccine, Industry, Medical imaging, Pharmaceutical industry, Orthopedic surgery, Ophthalmology

According to the report published by Allied Market Research, the global nanomedicine market was estimated at $171.69 billion in 2020 and is expected to hit $393.04 billion by 2030, registering a CAGR of 9.2% from 2021 to 2030.

Key Points: 
  • According to the report published by Allied Market Research, the global nanomedicine market was estimated at $171.69 billion in 2020 and is expected to hit $393.04 billion by 2030, registering a CAGR of 9.2% from 2021 to 2030.
  • Increase in R&D activities regarding nanorobots and significant investments in clinical trials by the government as well as private sector drive the growth of the global nanomedicine market.
  • Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/2021
    By modality, the treatments segment held the major share in 2020, garnering more than four-fifths of the global nanomedicine market.
  • By region, North America dominated in 2020, garnering nearly two-fifths of the global nanomedicine market.

Nanomedicine Market to Reach $393.04 Bn, Globally, by 2030 at 9.2% CAGR: Allied Market Research

Retrieved on: 
星期二, 三月 15, 2022
Nanotechnology, Degenerative disease, Nanomedicine, Urology, Treatment, Investment, Diagnosis, Government, CAGR, Lists of countries and territories, Neurology, Awareness, Private sector, Drug delivery, Regenerative medicine, Prevalence, Cancer, Incidence, Growth, Vaccine, Industry, Medical imaging, Pharmaceutical industry, Orthopedic surgery, Ophthalmology

PORTLAND, Ore., March 15, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Nanomedicine Market by Modality (Diagnostics and Treatment), Application (Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, Implants, and Others), and Indication (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Neurology, Urology, Ophthalmology, Immunology And Others): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report published by Allied Market Research, the global nanomedicine market was estimated at $171.69 billion in 2020 and is expected to hit $393.04 billion by 2030, registering a CAGR of 9.2% from 2021 to 2030.

Key Points: 
  • According to the report published by Allied Market Research, the global nanomedicine market was estimated at $171.69 billion in 2020 and is expected to hit $393.04 billion by 2030, registering a CAGR of 9.2% from 2021 to 2030.
  • Increase in R&D activities regarding nanorobots and significant investments in clinical trials by the government as well as private sector drive the growth of the global nanomedicine market.
  • Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/2021
    By modality, the treatments segment held the major share in 2020, garnering more than four-fifths of the global nanomedicine market.
  • By region, North America dominated in 2020, garnering nearly two-fifths of the global nanomedicine market.

Global Inhalable Drug Delivery Devices Report 2021 - Featuring Acorda Therapeutics, Actervis and Baxter International Among Others - ResearchAndMarkets.com

Retrieved on: 
星期五, 二月 4, 2022
Health, Pharmaceutical, Drug delivery, Pharmaceutical industry

The "Inhalable Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Inhalable Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive information about the Inhalable Drug Delivery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
  • Inhalable Drug Delivery device is meant to administer medications that are to be inhaled deeply into the lungs.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
    The report enables you to:
    In-depth analysis of the product's current stage of development, territory and estimated launch date

Drug Delivery Companies Compendium 2022 - Identify Product and Market Opportunities - ResearchAndMarkets.com

Retrieved on: 
星期二, 一月 11, 2022
Health, Pharmaceutical, Compendium, Intelligence, Drug delivery, Directory, Drug development, Medical device

The "Drug Delivery Companies Compendium 2022" directory has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Drug Delivery Companies Compendium 2022" directory has been added to ResearchAndMarkets.com's offering.
  • This report is a cost-effective, time saving product that answers all of your questions about the Drug Delivery companies worldwide.
  • This Compendium contains in-depth reference source information on the top players in drug delivery, their major technology platforms, and their strategic alliances.
  • This informative database enables users to monitor the people, the products and the financials behind today's global drug delivery market and will help you to:

Global Transdermal Drug Delivery Market, Technology and Competitive Landscape Report 2021 - ResearchAndMarkets.com

Retrieved on: 
星期一, 十一月 29, 2021
Pharmaceutical, Health, Medical Supplies, Blood, Skin, Parkinson's disease, Drug delivery, Birth, Angina, Nanoparticle, Hormone replacement therapy, Lists of diseases, Smoking cessation, Pain, Pharmaceutical industry

The "Transdermal Drug Delivery - Technologies, Markets, and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Transdermal Drug Delivery - Technologies, Markets, and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2020 to 2030.
  • This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral, intravascular, subcutaneous and transmucosal routes.
  • Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers.

Paper & Paperboard Packaging Market worth $254.5 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
星期一, 十一月 29, 2021
Knowledge, FBB, DS Smith, Personal, Plastic, Industry, Mondi, Glass, Income, CAGR, Region, Drug delivery, WLC, Health, USD, Amcor, GEM, SME, Paper, WestRock, Research, Metal, International Paper, Food, Lists of countries and territories, Growth, Whelping box, Plastic bottle, CUK, Content, Intelligence, SBS, Recycling, Cardboard, Marketing

The rising demand for sustainable and recycled packaging for food, healthcare, and personal & homecare applications will further drive the paper & paperboard packaging market.

Key Points: 
  • The rising demand for sustainable and recycled packaging for food, healthcare, and personal & homecare applications will further drive the paper & paperboard packaging market.
  • View Detailed Table of Content Here: https://www.marketsandmarkets.com/Market-Reports/paper-paperboard-packag...
    Food is expected to be the fastest-growing application in the Paper & paperboard packaging market during the forecast period.
  • It accounted for a share of about 42.2% of the paper & paperboard packaging market, in terms of value, in 2020.
  • APAC is expected to hold the largest market share in the global Paper & paperboard packaging market during the forecast period.

Global Drug Delivery Companies Compendium 2021 - ResearchAndMarkets.com

Retrieved on: 
星期三, 十一月 24, 2021
Pharmaceutical, Health, Transport, Logistics, Supply Chain Management, Compendium, Drug delivery, Drug development, Directory, Intelligence, Dietary supplement, Medical device

The "Drug Delivery Companies Compendium 2021" directory has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Drug Delivery Companies Compendium 2021" directory has been added to ResearchAndMarkets.com's offering.
  • The Drug Delivery Companies Compendium is a cost-effective, time saving product that answers all of your questions about the Drug Delivery companies worldwide.
  • Whether you are investing in drug delivery technologies R&D, selecting the right drug delivery system for your R&D products, or searching for the best licensing partner, the Drug Delivery Companies Compendium is for you
    Powerful drug development intelligence you can rely on.
  • This Compendium contains in-depth reference source information on the top players in drug delivery, their major technology platforms, and their strategic alliances.

Global Drug Delivery Deals Directory, 2014-2021 | 1,500+ Deals Available by Company A-Z, Headline Value, Stage of Development at Signing, Deal Component Type, Specific Therapy Target, Technology Type - ResearchAndMarkets.com

Retrieved on: 
星期一, 十一月 22, 2021
Health, Pharmaceutical, Chapter Three, Review, U.S. Securities and Exchange Commission, Mecum Dealmakers, Agreement, Drug delivery, It Takes Two, Chapter One, Confidentiality, SEC, Chapter Four, A-Z, Record, Securities & Exchange Commission of Pakistan, Hyperlink, Research, Orientation, Chapter Six, Ownership, Chapter Five, Intellectual property, Cryptocurrency, Pharmaceutical industry, Risk management, Bookkeeping, Publishing, Fine chemical, Birth control, Lease, Petroleum, Property management, Practice of law

The Global Drug Delivery Partnering Terms and Agreements 2014-2021 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.

Key Points: 
  • The Global Drug Delivery Partnering Terms and Agreements 2014-2021 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.
  • A comprehensive series of appendices is provided organized by Drug Delivery partnering company A-Z, stage of development, deal type, and therapy focus.
  • The Global Drug Delivery Partnering Terms and Agreements 2014-2021 report provides comprehensive access to available deals and contract documents for over 1500 Drug Delivery deals.
  • Global Drug Delivery Partnering Terms and Agreements 2014-2021 provides the reader with the following key benefits:
    Insight into terms included in a Drug Delivery partnering agreement, with real world examples

Global Transdermal Drug Delivery Market to Reach $7.4 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
星期五, 十月 1, 2021
Pharmaceutical, Health, Cardiology, Medical Devices, CAGR, CNS, Growth, COVID-19, Drug delivery, Transdermal patch, Pet

The "Transdermal Drug Delivery - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Transdermal Drug Delivery - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Transdermal Drug Delivery, estimated at US$4.9 Billion in the year 2020, is projected to reach a revised size of US$7.4 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027.
  • The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 5.7% CAGR
    The Transdermal Drug Delivery market in the U.S. is estimated at US$1.4 Billion in the year 2020.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$854.6 Million by the year 2027.